Top stories




Marketing & MediaThe New Generation Awards announces WesBank as its official headline naming sponsor
Lavello Marketing Solutions 17 hours


More news






Energy & Mining
Schneider Electric launches first Innovation Hub in Africa











While pharmaceutical companies have made ambitious commitments to improve access to medicines in underserved populations, the report reveals significant gaps in their efforts. Despite the increasing demand for life-saving healthcare products, many people in low- and middle-income countries (LMICs) still lack access to essential medications. Measuring patient reach is crucial to determining whether essential medicines and healthcare products are truly reaching the people who need them most. It provides valuable insights into gaps in access and helps ensure that healthcare efforts are both effective and equitable.
The latest report from the Access to Medicine Foundation addresses this critical issue of how pharma companies are reaching people worldwide especially in LMICs.
To address these challenges, the report highlights recommendations for the pharma industry:
By taking these steps, pharmaceutical companies can play a crucial role in closing the gap in healthcare access and improving the health outcomes of people around the world.